1
2
3
Loveikyte, R, Boer, M, van der Meulen, C N, ter Steege, R W F, Tack, G, Kuyvenhoven, J, Jharap, B, Vu, M K, Vogelaar, L, West, R L, van der Marel, S, Römkens, T, Mujagic, Z, Hoentjen, F, van Bodegraven, A A, van Schaik, F D M, de Vries, A C, Dijkstra, G, van der Meulen-de Jong, A E
Veröffentlicht in: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i589-i589 ; ISSN 1873-9946 1876-4479;
2022
Veröffentlicht in: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i589-i589 ; ISSN 1873-9946 1876-4479;
2022
4
Prevalence of-And risk factors for work disability in Dutch patients with inflammatory bowel disease
Spekhorst, L.M. (Lieke M.), Oldenburg, B. (Bas), Bodegraven, A.A. (Ad) van, De Jong, D.J. (Dirk J.), Imhann, F. (Floris), Van De Meulen-De Jong, A.E. (Andrea E.), Pierik, M. (Marieke), Van Der Woude, J.C. (Janneke C.), Dijkstra, G. (Gerard), D'Haens, G. (Geert), Löwenberg, M., Weersma, R.K. (Rinse), Festen, E.A.M. (Eleonora)
2017
2017
5
Biemans, V.B.C., Sleutjes, J.A.M., de Vries, A.C., Bodelier, A.G.L., Dijkstra, G., Oldenburg, B., Lowenberg, M., van Bodegraven, A.A., van der Meulen-de Jong, A.E., de Boer, N.K.H., Srivastava, N., West, R.L., Romkens, T.E.H., Horje, C.H.T.S., Jansen, J.M., van der Woude, C.J., Hoekstra, J., Weersma, R.K., van Schaik, F.D.M., Hoentjen, F., Pierik, M.J.
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Lowenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Romkens , T E H , Horje , C H T S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & Dutch Initiative Crohn and Colitis 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology & Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Lowenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Romkens , T E H , Horje , C H T S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & Dutch Initiative Crohn and Colitis 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology & Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020